Description
PTC124 allows read-through of premature stop codons in mRNA, enabling proper protein translation. This compound is used to treat Duchenne muscular dystrophy (DMD) and cystic fibrosis as well as other nonsense mutation disorders.
PTC124 allows read-through of premature stop codons in mRNA, enabling proper protein translation. This compound is used to treat Duchenne muscular dystrophy (DMD) and cystic fibrosis as well as other nonsense mutation disorders.
Cas No. | 775304-57-9 |
---|---|
Purity | ≥98% |
Formula | C15H9FN2O3 |
Formula Wt. | 284.25 |
IUPAC Name | 3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]benzoic acid |
Synonym | PTC-124, Ataluren, Translarna™ |
Solubility | DMSO 57 mg/mL (200mM) Water Insoluble Ethanol Insoluble |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Bushby K, Finkel R, Wong B, et al. Ataluren treatment of patients with nonsense mutation dystrophinopathy. Muscle Nerve. 2014 Oct;50(4):477-87. PMID: 25042182.
Ryan NJ. Ataluren: first global approval. Drugs. 2014 Sep;74(14):1709-14. PMID: 25193627.
Nagel-Wolfrum K, Möller F, Penner I, et al. Translational read-through as an alternative approach for ocular gene therapy of retinal dystrophies caused by in-frame nonsense mutations. Vis Neurosci. 2014 Sep;31(4-5):309-16. PMID: 24912600.
CDK inhibitor.
Imaging agent; Maillard reaction inhibitor.
Nucleoside (cytidine) analog; DNMT inhibitor, p...
Inhibitor of EGFR, HER2, and HER3.
Peptide; galanin antagonist.
Endogenous peptide hormone fragment, involved i...
Recombinant chimeric protein containing Trepone...
Nitrogen mustard, DNA alkylator.
Paclitaxel derivative
Semi-synthetic taxane.
Mycotoxin produced by Aspergillus; actin polyme...
Byproduct of L-arginine metabolism found in wat...
Cannabinoid receptor 2 selective agonist.
Nicotinic acid derivative; InhA inhibitor.
FGFR inhibitor.
Nucleoside (adenosine) analog; DNA chain termin...
Mycotoxin produced by Fusarium fungi that infec...
Modifies microvascular function
p110α PI3K and mTOR inhibitor.
SIRT1/2 inhibitor, indirect p53 activator.